Arvinas Competitors and Similar CompaniesClear all
Arvinas's competitors and similar companies include Lyell.
 Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. | ||
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New Haven, US HQ | Locations South San Francisco, US HQ Bothell, US Seattle, US |
Employees | Employees 13329% increase | Employees 188 |
Valuation ($) | Valuation ($) 1.9 b | Valuation ($) 243.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $262.6m (FY, 2025) | Revenue (est.) $36k (FY, 2025) |
Net income | Net income ($80.8m) (FY, 2025) | Net income ($274.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Lyell
HQ
South San Francisco, US
Employees
188
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View company